Increased serum levels of LL37, HMGB1 and S100A9 during exacerbation in COPD patients

European Respiratory Journal

Volumn 45, Issue 5, 2015, Pages 1482-1485

  Pouwels, Simon D ^a   Nawijn, Martijn C ^a   Bathoorn, Erik ^a   Riezebos Brilman, Annelies ^a   Van Oosterhout, Antoon J M ^a   Kerstjens, Huib A M ^a   Heijink, Irene H ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; CALGRANULIN B; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; DOUBLE STRANDED DNA; GALECTIN 3; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 8; MITOCHONDRIAL DNA; CATHELICIDIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE; HMGB1 PROTEIN, HUMAN;

ADULT; BACTERIAL INFECTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CYTOKINE PRODUCTION; DISEASE EXACERBATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LETTER; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY TRACT INFLAMMATION; SERUM; SEX DIFFERENCE; SPUTUM ANALYSIS; VIRAL RESPIRATORY TRACT INFECTION; AGED; BLOOD; COMPLICATION; CONTROLLED STUDY; DISEASE COURSE; GENE EXPRESSION REGULATION; INFLAMMATION; MIDDLE AGED; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; VIRUS INFECTION;

AGED; BACTERIAL INFECTIONS; CALGRANULIN B; CATHELICIDINS; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION; HMGB1 PROTEIN; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; SEX FACTORS; VIRUS DISEASES;

EID: 84929012503     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00158414     Document Type: Letter

References (16)

1. Brusselle GG, Joos GF, Bracke KR. New insights into the immunology of chronic obstructive pulmonary disease. Lancet 2011; 378: 1015-1026.
2. Decramer M, Janssens W, Miravitlles M. Chronic obstructive pulmonary disease. Lancet 2012; 379: 1341-1351.
3. Bathoorn E, Liesker JJ, Postma DS, et al. Change in inflammation in out-patient COPD patients from stable phase to a subsequent exacerbation. Int J Chron Obstruct Pulmon Dis 2009; 4: 101-109.
4. Chen GY, Nuñez G. Sterile inflammation: Sensing and reacting to damage. Nat Rev Immunol 2010; 10: 826-837.
5. Pouwels SD, Heijink IH, ten Hacken NH, et al. DAMPs activating innate and adaptive immune responses in COPD. Mucosal Immunol 2014; 7: 215-226.
6. Pouwels SD, Heijink IH, van Oosterhout AJ, et al. A specific DAMP profile identifies susceptibility to smoke-induced airway inflammation. Eur Respir J 2014; 43: 1183-1186.
7. Repapi E, Sayers I, Wain LV, et al. Genome-wide association study identifies five loci associated with lung function. Nat Genet 2010; 42: 36-44.
8. Castaldi PJ, Cho MH, Litonjua AA, et al. The association of genome-wide significant spirometric loci with chronic obstructive pulmonary disease susceptibility. Am J Respir Cell Mol Biol 2011; 45: 1147-1153.
9. Cockayne DA, Cheng DT, Waschki B, et al. Systemic biomarkers of neutrophilic inflammation, tissue injury and repair in COPD patients with differing levels of disease severity. PLoS One 2012; 7: e38629.
10. Bathoorn E, Liesker JJ, Postma DS, et al. Anti-inflammatory effects of combined budesonide/formoterol in COPD exacerbations. COPD 2008; 5: 282-290.
11. Zhang Q, Raoof M, Chen Y, et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 2010; 464: 104-107.
12. Roundy LM, Jia W, Zhang J, et al. LL-37 induced cystitis and the receptor for advanced glycation end-products (RAGE) pathway. Adv Biosci Biotechnol 2013; 4: 1-8.
13. Zhang J, Xu X, Rao NV, et al. Novel sulfated polysaccharides disrupt cathelicidins, inhibit RAGE and reduce cutaneous inflammation in a mouse model of rosacea. PLoS One 2011; 6: e16658.
14. Iwamoto H, Gao J, Pulkkinen V, et al. Soluble receptor for advanced glycation end-products and progression of airway disease. BMC Pulm Med 2014; 14: 68.
15. Gopal P, Reynaert NL, Scheijen JL, et al. Association of plasma sRAGE, but not esRAGE with lung function impairment in COPD. Respir Res 2014; 15: 24.
16. Smith DJ, Yerkovich ST, Towers MA, et al. Reduced soluble receptor for advanced glycation end-products in COPD. Eur Respir J 2011; 37: 516-522.